Ten years of ciprofloxacin: the past, present and future. Serious hospital infections. Introduction

Affiliations

Comment

M H Wilcox. J Antimicrob Chemother. 1999 Mar.

. 1999 Mar:43 Suppl A:115.

No abstract available

Comment on

Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
Krumpe PE, Cohn S, Garreltes J, Ramirez J, Coulter H, Haverstock D, Echols R. Krumpe PE, et al. J Antimicrob Chemother. 1999 Mar;43 Suppl A:117-28. doi: 10.1093/jac/43.suppl_1.117. J Antimicrob Chemother. 1999. PMID: 10225582 Clinical Trial.
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW, Singh S, Johnson RH. Caldwell JW, et al. J Antimicrob Chemother. 1999 Mar;43 Suppl A:129-34. J Antimicrob Chemother. 1999. PMID: 10225583 Clinical Trial.